Idexx Laboratories, Inc. Earnings

Idexx Laboratories, Inc.’s revenue jumped 13.29% since last year same period to $1105.24Mn in the Q3 2025. On a quarterly growth basis, Idexx Laboratories, Inc. has generated -0.38% fall in its revenue since last 3-months.

Idexx Laboratories, Inc.’s net profit jumped 17.94% since last year same period to $274.61Mn in the Q3 2025. On a quarterly growth basis, Idexx Laboratories, Inc. has generated -6.59% fall in its net profits since last 3-months.

Idexx Laboratories, Inc.’s net profit margin jumped 4.1% since last year same period to 24.85% in the Q3 2025. On a quarterly growth basis, Idexx Laboratories, Inc. has generated -6.24% fall in its net profit margins since last 3-months.

Idexx Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.13 - a -5.15% fall from last quarter’s estimates.

Idexx Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 3.13.

Idexx Laboratories, Inc.’s earning per share (EPS) jumped 15.89% since last year same period to 3.5 in the Q2 2025. This indicates that the Idexx Laboratories, Inc. has generated 15.89% annual rate of jump in its earning per share (EPS) in the last 4 quarters.